iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
de Jong, W., Aerts, J., Allard, S., Brander, C., Buyze, J., Florence, E., Van Gorp, E., Vanham, G., Leal, J., … Read More